Bioshares Biotech Clinical Trial (BBC)
$43.32 0.75 (1.70%)
20:00 EDT BBC Stock Quote Delayed 30 Minutes
Previous Close $43.32
Market Cap 99.64M
PE Ratio -
Volume (Avg. Vol.) 42,200
Day's Range 42.75 - 44.58
52-Week Range 22.92 - 45.70
Dividend & Yield 0.30 (0.69%)
BBC Stock Predictions, Articles, and Bioshares Biotech Clinical Trial News
- From InvestorPlace
- From the Web
The fourth quarter has been a different story. IBB, the largest biotech ETF by assets, is up 16.65% since Oct. 1, pushing its year-to-date gain to 26.57% as of Dec. 20. That after months of investors pulling money from actively managed biotech funds, but that situation is starting to correct as well as data out this month indicate investors are warming to biotech assets again.
While P/E alone fails to identify a true value stock, PEG helps determine the intrinsic value of a stock. Compare Brokers....
These were the some of the best ETFs in January. Each outperformed the S&P 500 by at least 5% or more. Here's what investors need to know about each ETF.
Let's take a look Inside four heavily losing ETFs in the year-to-date frame.
Finding biotech stocks to invest in involves some level of danger. Use these tips to help determine your best bets, and start with these 3 biotechs to buy
We can look for common issues that have appeared in the past before significant corrections, and from that perspective, biotechnology looks overheated.
The Inside ETFs Conference is one of the most interesting investment meetings of the year. Unlike other ETF industry gatherings, the Inside ETFs Conference, sponsored by website ETF.com, is the largest meet up in the business. With some 2,000 professional attendees all looking for the latest and greatest ways to use ETFs as part of their investment portfolios, this conference tends to generate buzz on the next wave of best ETF ideas.